Rosette Nanotubes for Targeted Drug Delivery

Abstract

The sections in this article are Introduction Peptide-Based Nanotubes Self-Assembling Rosette Nanotubes Self-Assembly Peptides G∧C Motif Self-Assembly: Novel Helical Rosette Nanotubes Novelty G∧C Motif Self-Assembly Process Built-In Strategy for Manipulating the Properties of RNTs Biological Functions of RNTs Stability Issues Nanomaterials for Receptor-Mediated Targeting Human Epidermal Growth Factor Receptor (EGFR) Vasoactive Pituitary Adenylate Cyclase (VPAC)-Activating Peptide Receptors Transferrin Receptor (TfR) Folate Receptor (FR) Ethical Issues and Future Directions Conclusions Keywords: biofriendly nanotubes; drug delivery; cancer; inflammation; nanotechnology